Autologous multi-lineage potential cells (Lai Corporation)

N/A

Report date: 2024/11/13 20:00:43

Base Information

Drug NameAutologous multi-lineage potential cells (Lai Corporation)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryThailand
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLai Corporation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLai Corporation Pty Ltd
Active IndicationsN/A
Inactive IndicationsLeukemia, Myeloid, Acute

Other Information

ATC CodeN/A
Related LinksN/A